a.nascimento

TL2 · Setúbal

Contributes reviews on supplier material. Based in Setúbal.

Joined 19 February 2025 · last posted 3h

84 posts, newest first. Showing up to 150.

Prescription portability between countries Replied, post #115 · Access › International · 28 Jul 2026 · 2 likes I came in to disagree and I am leaving without a disagreement.
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #89 · Analytics › Method validation · 14 Jul 2026 · 7 likes Accuracy for a purity assay is usually demonstrated by spike recovery across a range. Without a reference standard, that is exactly the work that cannot be done, which…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #126 · Start Here › How to Ask · 13 Jul 2026 · 14 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
Coming back to: A newcomer's list of things that confused me, and the fixes Replied, post #9 · Start Here › Welcome · 5 Jul 2026 · 22 likes Reading the guidelines before you post is genuinely worth the twenty minutes. Not because you will break one, but because the rules explain why the place reads the way…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #65 · Wellbeing › Sleep · 21 Jun 2026 · 6 likes Post #64 is the version of this I will quote in future. One addition. Energy availability affects sleep in both directions, and a large deficit can produce either…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #3 · Compounds › Secretagogues & GH axis · 20 Jun 2026 · 12 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
Lipid changes during rapid weight loss: the expected trajectory Replied, post #3 · marked as the solution · Clinical › Bloodwork · 6 Jun 2026 · 11 likes If someone has run lipid changes during rapid weight properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone…
The most useful thing you learned here that was not the answer you came for Replied, post #44 · Lounge › Off topic · 22 May 2026 · 2 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #78 · Outcomes › Body composition · 18 May 2026 · 10 likes Practical answer on Lean mass preservation, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
[2026 update] Waist circumference technique and its repeatability Replied, post #10 · Outcomes › Progress reports · 17 May 2026 · 0 likes Circumference measurements at marked sites are cheap, reproducible within a person, and more informative than they get credit for.
Amylin receptor signalling and satiety — what changed since Replied, post #74 · Pharmacology › Receptor biology · 5 May 2026 · 22 likes In vitro potency and clinical potency are related by a long chain of assumptions. A compound more potent at the receptor is not necessarily more effective at a…
Run-in periods and the population they select Replied, post #109 · Evidence › Trials · 1 May 2026 · 0 likes I read the earlier replies on run-in periods twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #21 · Clinical › Comorbidities · 27 Apr 2026 · 0 likes Adding a null result on PCOS and metabolic overlap. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #115 · Analytics › Mass spectrometry · 26 Apr 2026 · 9 likes No disagreement from me. Posting only so the question does not look ignored.
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #24 · Practice › Reconstitution · 25 Apr 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
The best-written scientific paper you have read Replied, post #17 · Lounge › Off topic · 24 Apr 2026 · 3 likes A methods point on best-written scientific paper rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #93 · Practice › Reconstitution · 24 Apr 2026 · 6 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #78 · Practice › Reconstitution · 23 Apr 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. If anyone has…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #10 · Practice › Reconstitution · 17 Apr 2026 · 27 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Spike-and-recover accuracy for a peptide assay Replied, post #97 · Analytics › Method validation · 10 Apr 2026 · 18 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. The interesting part of…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #101 · Analytics › Mass spectrometry · 9 Apr 2026 · 29 likes My experience of Adducts contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #36 · Sourcing › Independent verification · 2 Apr 2026 · 12 likes I had written a reply contradicting post #34 and deleted it. Here is what survived. A methods point on Janoshik rather than a substantive one: if the comparison is not…
[2026 update] Thyroid function tests during substantial weight change Replied, post #17 · Clinical › Bloodwork · 18 Mar 2026 · 0 likes Picking up post #14: that is the part I would want checked first. I would keep Thyroid function tests during substantial and the decision it usually gets used for…
A site rotation scheme that is easy enough to actually follow Replied, post #17 · Practice › Administration · 9 Mar 2026 · 0 likes Agreed on site rotation scheme, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #62 · Sourcing › Regulatory · 24 Feb 2026 · 0 likes Worth stating the null on compound being unapproved before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #22 · Analytics › Impurities & related substances · 22 Feb 2026 · 23 likes I had written a reply contradicting post #20 and deleted it. Here is what survived. Careful with the language on impurities in solid-phase peptide synthesis. "Not…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #2 · Practice › Interactions · 20 Feb 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
Trifluoroacetate content and its consequences Replied, post #20 · Analytics › Impurities & related substances · 25 Jan 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #50 · Sourcing › Red flags · 14 Jan 2026 · 28 likes Building on post #48 rather than restating it. Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time…
Coming back to: Training through a dose escalation week Replied, post #7 · Nutrition & Training › Resistance training · 12 Jan 2026 · 0 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
Search filters: what is missing Replied, post #14 · Meta › Site feedback · 1 Jan 2026 · 0 likes The thing about search filters that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Aggregates and why a purity assay may miss them entirely Replied, post #40 · Analytics › Impurities & related substances · 31 Dec 2025 · 0 likes Post #39 describes the usual case. This is about the unusual one. On aggregates, the part that usually goes wrong is that the question is asked as though it has one…
Vomiting: when it is expected and when it is a reason to stop Replied, post #80 · Practice › Side effects · 29 Dec 2025 · 1 like The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Can a home kit substitute for a laboratory report? A careful no Replied, post #82 · Analytics › Home & field testing · 18 Dec 2025 · 2 likes Reagent shelf life is a real constraint on kits and is frequently ignored. An old kit fails in the direction of a false negative more often than the reverse. That is…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #37 · Access › Pricing · 14 Dec 2025 · 0 likes The failure mode on Price changes is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #112 · Documentation › Doc review · 14 Dec 2025 · 1 like A promotion that is declined should leave the topic linked from wherever the question recurs, so the work is not lost.
Publishing an inconvenient result: a case study — the long version Replied, post #64 · Sourcing › Independent verification · 9 Dec 2025 · 0 likes Speaking only to Publishing an inconvenient result as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #5 · Sourcing › Logistics · 7 Dec 2025 · 29 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #6 · Compounds › Tirzepatide · 29 Nov 2025 · 23 likes Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme. Individual reports here vary in both directions, which is what you…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #26 · Compounds › Other compounds · 23 Nov 2025 · 23 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
Moderation log format change Replied, post #9 · Meta › Announcements · 18 Nov 2025 · 19 likes The version of moderation log format change that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
The anatomy of a question that gets answered within an hour — the long version Replied, post #110 · Start Here › How to Ask · 18 Nov 2025 · 1 like Post #106 put the caveat in the right place and I want to underline it. If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse —…
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #10 · Analytics › Impurities & related substances · 14 Nov 2025 · 0 likes The honest answer on Aggregates is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #75 · Documentation › Doc review · 15 Oct 2025 · 0 likes That is consistent with mine, for whatever one more account is worth.
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #45 · Compounds › Oral incretins · 3 Oct 2025 · 20 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
Why the timeline is on the right and not the left Replied, post #68 · Meta › Site feedback · 14 Sep 2025 · 0 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #3 · Evidence › Study critique · 12 Sep 2025 · 4 likes Posting my Reverse causation numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #38 · Practice › Dosing & titration · 7 Sep 2025 · 0 likes This follows post #37 rather than contradicting it. The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the…
A parcel that arrived warm: a decision process, not a verdict Replied, post #28 · Practice › Storage & stability · 7 Sep 2025 · 7 likes The arithmetic in post #25 is right; the assumption feeding it is the part to check. Clarity is a weak test. A solution can lose a significant fraction of its active…
Meeting a protein target on a suppressed appetite Replied, post #19 · Nutrition & Training › Protein & intake · 2 Sep 2025 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #92 · Compounds › Cagrilintide & amylin analogues · 2 Sep 2025 · 10 likes Cagrisema phase 2 paper is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
Second pass at: The mass-error checker and its intended scope Replied, post #9 · Data & Tools › Calculators · 31 Aug 2025 · 0 likes Whatever the answer on mass-error checker turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #96 · Data & Tools › Calculators · 27 Aug 2025 · 3 likes Distinguishing three things in the titration planner refuses discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
A request that was declined, and the reasoning — a second dataset Replied, post #23 · Documentation › Wiki requests · 7 Aug 2025 · 1 like Post #21 describes the usual case. This is about the unusual one. A calculator request and a document request are different things, and a calculator without a document…
Coming back to: Official shortage notices and what they authorise Replied, post #65 · Access › Shortages · 22 Jul 2025 · 7 likes Coming back to post #61, because the follow-up matters more than the original answer. International supply chains: a shortage in one country does not mean shortage in…
Publishing an inconvenient result: a case study Replied, post #41 · Sourcing › Independent verification · 29 Jun 2025 · 5 likes Appreciated. The plain phrasing does more work here than a longer post would.
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #60 · Clinical › Comorbidities · 27 Jun 2025 · 2 likes Building on post #57 rather than restating it. Source for the Cardiovascular risk figure, since it was asked for. It is in the discussion rather than the abstract,…
Why oral semaglutide needs an absorption enhancer at all Replied, post #14 · Compounds › Oral incretins · 25 Jun 2025 · 0 likes Post #12 put the caveat in the right place and I want to underline it. Tablet integrity matters more than people expect for a formulation that depends on an absorption…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #59 · Clinical › Comorbidities · 7 Jun 2025 · 0 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
A report I filed that turned out to be wrong, and the correction Replied, post #87 · Sourcing › Vendor reports · 5 Jun 2025 · 0 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. Not a conclusion. A…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #77 · Practice › Reconstitution · 25 May 2025 · 0 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #13 · Sourcing › Independent verification · 25 Apr 2025 · 2 likes My understanding of Janoshik is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Preparing for an appointment: one page, three questions Replied, post #15 · Clinical › Prescriber conversations · 18 Apr 2025 · 12 likes Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done.
Carryover and the ghost peak from last week's standard Replied, post #11 · Analytics › HPLC & UHPLC · 2 Apr 2025 · 24 likes Two things can be true about carryover at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
Coming back to: What published stability data actually covers, and what it does not Replied, post #13 · Practice › Storage & stability · 30 Mar 2025 · 3 likes Seconded. It reads as careful rather than confident, which is the right register.
Retatrutide dose escalation in the published trials Replied, post #63 · Compounds › Retatrutide · 29 Mar 2025 · 23 likes On dose escalation: the published protocols escalated in defined steps over defined intervals, and those intervals were chosen to manage tolerability. Compressing them…
Coverage for the indication versus for the drug Replied, post #8 · Access › Insurance & coverage · 23 Mar 2025 · 0 likes Post #7 answers the question as asked. The question underneath it is different. An honest declaration on coverage: I have a prior here and it is strong enough that you…
Why cagrilintide alone is discussed so much less than in combination Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 22 Mar 2025 · 15 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #93 · Sourcing › Regulatory · 3 Mar 2025 · 9 likes Understood, and I withdraw the assumption I opened with.
Follow-up: Individual participant data versus aggregate data Replied, post #73 · Evidence › Meta-analyses · 10 Jan 2025 · 3 likes I would rather this thread reach "we do not know" about Individual participant data versus aggregate than reach a confident answer that nobody can support when asked.
When "no data" is the complete and final answer Replied, post #58 · Compounds › Other compounds · 5 Jan 2025 · 21 likes Post #55 answers the question as asked. The question underneath it is different. Anyone submitting an unusual compound for testing should tell the laboratory what it is…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #102 · Compounds › Oral incretins · 28 Dec 2024 · 12 likes That reframing is the whole thing. The facts I already had.
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #10 · Compounds › Semaglutide · 16 Dec 2024 · 7 likes Noted, and thank you for writing it out rather than summarising it.
[2026 update] New subcategory: rationale and scope Replied, post #68 · Meta › Announcements · 15 Dec 2024 · 25 likes Building on post #66 rather than restating it. I would put moderate confidence on the mainstream reading of New subcategory and no more. That is not scepticism for its…
Injection-site reactions: describing them precisely enough to be useful Replied, post #50 · Practice › Side effects · 6 Dec 2024 · 5 likes Post #47 is the version of this I will quote in future. One addition. Adding what did not work for me on injection-site reactions, since the failures never get written…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #52 · Compounds › Semaglutide · 30 Nov 2024 · 0 likes Counter-ion form matters for the arithmetic and is almost never stated. A vial labelled 5 mg of peptide as an acetate salt and one labelled 5 mg as trifluoroacetate do…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #141 · Compounds › Repair & healing peptides · 25 Nov 2024 · 4 likes Reading a preclinical wound-healing model has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
How to ask for a dose change without antagonising anyone — what changed since Replied, post #93 · Clinical › Prescriber conversations · 23 Nov 2024 · 6 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. I would rather say I do not know than round it up to…
When to suspect the method rather than the sample Replied, post #16 · Analytics › Method validation · 25 Sep 2024 · 12 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. Specificity: the method can distinguish the intended compound from…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #81 · Sourcing › Independent verification · 24 Sep 2024 · 0 likes Taking post #80 at face value and following it one step further. The record shows what was measured. Everything beyond that is inference and this site tries to keep the…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #4 · Compounds › Other compounds · 15 Sep 2024 · 24 likes The reason Melanocortin agonists keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #9 · Compounds › Semaglutide · 11 Sep 2024 · 1 like On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
The topic list is dense — is that deliberate? Replied, post #18 · Meta › Site feedback · 26 Aug 2024 · 11 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters. One of those cases…
Guidelines revision: what changed and why Replied, post #13 · Meta › Announcements · 25 Jul 2024 · 0 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…